Wells Fargo & Company Immuno Gen, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$12.46 - $29.95 $2.03 Million - $4.87 Million	-162,652 Reduced 66.98%	80,191 $2.38 Million
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $264,835 - $373,476	18,796 Added 8.39%	242,843 $3.85 Million
Q2 2023 Aug 15, 2023	SELL	$3.75 - $20.05 $770,523 - $4.12 Million	-205,473 Reduced 47.84%	224,047 $4.23 Million
Q1 2023 May 12, 2023	BUY	$3.67 - $4.92 $1.13 Million - $1.51 Million	307,204 Added 251.16%	429,520 $1.65 Million
Q4 2022 Feb 13, 2023	SELL	$4.55 - $6.31 $1.87 Million - $2.6 Million	-411,324 Reduced 77.08%	122,316 $606,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $486,299 - $702,312	-108,549 Reduced 16.9%	533,640 $2.55 Million
Q2 2022 Aug 12, 2022	SELL	$3.15 - $5.76 $562,807 - $1.03 Million	-178,669 Reduced 21.77%	642,189 $2.89 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $25,905 - $45,485	-6,081 Reduced 0.74%	820,858 $3.91 Million
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $611,054 - $964,822	-128,643 Reduced 13.46%	826,939 $6.14 Million
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $117,272 - $153,948	-23,361 Reduced 2.39%	955,582 $5.42 Million
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $722,893 - $1.07 Million	-124,852 Reduced 11.31%	978,943 $6.45 Million
Q1 2021 May 13, 2021	SELL	$6.5 - $10.53 $1.55 Million - $2.51 Million	-238,552 Reduced 17.77%	1,103,795 $8.94 Million
Q4 2020 Feb 09, 2021	SELL	$3.7 - $7.66 $138,213 - $286,139	-37,355 Reduced 2.71%	1,342,347 $8.66 Million
Q3 2020 Nov 05, 2020	BUY	$3.45 - $4.89 $40,820 - $57,858	11,832 Added 0.86%	1,379,702 $4.97 Million
Q2 2020 Aug 13, 2020	BUY	$3.32 - $5.34 $768,852 - $1.24 Million	231,582 Added 20.38%	1,367,870 $6.29 Million
Q1 2020 May 14, 2020	BUY	$2.12 - $6.8 $2.41 Million - $7.73 Million	1,136,288 New	1,136,288 $3.88 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account